Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis.

Tahtamouni L, Ahram M, Koblinski J, Rolfo C.

Anal Cell Pathol (Amst). 2019 May 14;2019:1356508. doi: 10.1155/2019/1356508. eCollection 2019. No abstract available.

2.

The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.

Abualhaj NZ, Dardas Z, Azab B, Ali D, Sughayer MA, Aladily TN, Ahram M.

Ann Diagn Pathol. 2019 Apr;39:53-58. doi: 10.1016/j.anndiagpath.2019.01.004. Epub 2019 Jan 24.

PMID:
30718223
3.

TPP2 mutation associated with sterile brain inflammation mimicking MS.

Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschländer A, Meuth SG, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick AD, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A.

Neurol Genet. 2018 Nov 13;4(6):e285. doi: 10.1212/NXG.0000000000000285. eCollection 2018 Dec.

4.

Expression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from Jordan.

Obeidat FN, Ahram M, Al-Khader A, Mbaideen SA, Hassan H, Altarawneh B, Battah K.

Ann Saudi Med. 2018 Sep-Oct;38(5):326-335. doi: 10.5144/0256-4947.2018.326.

5.

Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma.

Ahram M, Amarin JZ, Suradi HH, Abdelhamid SS, Makhamreh MM, Bawadi RM, Al-Hussaini M.

J Mol Neurosci. 2018 Nov;66(3):307-313. doi: 10.1007/s12031-018-1178-z. Epub 2018 Sep 25.

PMID:
30255441
6.

Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.

Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M.

Anticancer Agents Med Chem. 2018;18(9):1330-1337. doi: 10.2174/1871520618666180808100800.

PMID:
30088453
7.

Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.

Al-Othman N, Hammad H, Ahram M.

Gene. 2018 Oct 30;675:128-135. doi: 10.1016/j.gene.2018.06.094. Epub 2018 Jun 28.

PMID:
29964098
8.

The cellular and molecular effects of the androgen receptor agonist, Cl-4AS-1, on breast cancer cells.

Ahram M, Mustafa E, Abu Hammad S, Alhudhud M, Bawadi R, Tahtamouni L, Khatib F, Zihlif M.

Endocr Res. 2018 Aug;43(3):203-214. doi: 10.1080/07435800.2018.1455105. Epub 2018 Mar 26.

PMID:
29578828
9.

Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.

Rouibah H, Kebsa W, Lahouel M, Zihlif M, Ahram M, Aburmeleih B, Mustafa E, Al-Ameer HJ.

Anticancer Agents Med Chem. 2018;18(3):375-387. doi: 10.2174/1871520618666180110143239. Erratum in: Anticancer Agents Med Chem. 2018;18(9):1364.

PMID:
29318976
10.

Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital.

Obeidat F, Ahram M, Al Khader A, Battah K, Alchalabi M, Melhem JM, Suleiman A.

J Pak Med Assoc. 2017 Aug;67(8):1206-1212.

11.

Differential expression and androgen regulation of microRNAs and metalloprotease 13 in breast cancer cells.

Ahram M, Mustafa E, Zaza R, Abu Hammad S, Alhudhud M, Bawadi R, Zihlif M.

Cell Biol Int. 2017 Dec;41(12):1345-1355. doi: 10.1002/cbin.10841. Epub 2017 Sep 5.

PMID:
28816390
12.

Factors Influencing Dental Patient Participation in Biobanking and Biomedical Research.

Hassona Y, Ahram M, Odeh N, Abu Gosh M, Scully C.

Med Princ Pract. 2016;25(4):323-8. doi: 10.1159/000446479. Epub 2016 May 10.

13.

Alteration of gene expression in MDA-MB-453 breast cancer cell line in response to continuous exposure to Trastuzumab.

Sharieh EA, Awidi AS, Ahram M, Zihlif MA.

Gene. 2016 Jan 10;575(2 Pt 2):415-420. doi: 10.1016/j.gene.2015.09.019. Epub 2015 Sep 12.

PMID:
26367328
14.

Knowledge, Attitudes, and Practice Regarding Genetic Testing and Genetic Counselors in Jordan: A Population-Based Survey.

Ahram M, Soubani M, Abu Salem L, Saker H, Ahmad M.

J Genet Couns. 2015 Dec;24(6):1001-10. doi: 10.1007/s10897-015-9839-3. Epub 2015 Apr 8.

PMID:
25851945
15.

Quitting smoking and utilization of smoking cessation services in Jordan: a population-based survey.

Jaghbir M, Shareif S, Ahram M.

East Mediterr Health J. 2014 Oct 12;20(9):538-46.

16.

Pattern of cigarette and waterpipe smoking in the adult population of Jordan.

Jaghbir M, Shreif S, Ahram M.

East Mediterr Health J. 2014 Oct 12;20(9):529-37.

17.

Knowledge, attitudes and practices of breast cancer screening among women in Jordan.

Othman A, Ahram M, Al-Tarawneh MR, Shahrouri M.

Health Care Women Int. 2015;36(5):578-92. doi: 10.1080/07399332.2014.926900. Epub 2014 Aug 13.

PMID:
24911030
18.

Towards establishing a multiple sclerosis biobank in Jordan.

Ahram M, Zaza R, Ibayyan L, Dahbour S, Bahou Y, El-Omar A, Samhouri B, El-Khateeb M.

Int J Neurosci. 2014 Nov;124(11):812-7. doi: 10.3109/00207454.2014.886204. Epub 2014 Feb 28.

PMID:
24456262
19.

The promoter SNP, but not the alternative splicing SNP, is linked to multiple sclerosis among Jordanian patients.

Ibayyan L, Zaza R, Dahbour S, El-Omar A, Samhouri B, El-Khateeb M, Ahram M.

J Mol Neurosci. 2014 Apr;52(4):467-72. doi: 10.1007/s12031-013-0151-0. Epub 2013 Oct 30.

PMID:
24166352
20.

Media use for seeking health/cancer-related information: findings from knowledge, attitudes and practices towards cancer prevention and care survey in Jordan.

Akhu-Zaheya LM, Jagbir MT, Othman A, Ahram M.

Int J Nurs Pract. 2014 Dec;20(6):608-15. doi: 10.1111/ijn.12196. Epub 2013 Oct 11.

PMID:
24118581
21.

Factors influencing public participation in biobanking.

Ahram M, Othman A, Shahrouri M, Mustafa E.

Eur J Hum Genet. 2014 Apr;22(4):445-51. doi: 10.1038/ejhg.2013.174. Epub 2013 Aug 7.

22.

Public support and consent preference for biomedical research and biobanking in Jordan.

Ahram M, Othman A, Shahrouri M.

Eur J Hum Genet. 2013 May;21(5):567-70. doi: 10.1038/ejhg.2012.213. Epub 2012 Sep 12.

23.

Public perception towards biobanking in jordan.

Ahram M, Othman A, Shahrouri M.

Biopreserv Biobank. 2012 Aug;10(4):361-5. doi: 10.1089/bio.2012.0010. Erratum in: Biopreserv Biobank. 2012 Dec;10(6):550.

PMID:
24849885
24.

Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients.

Ahram M, El-Omar A, Baho Y, Lubad MA.

Acta Neurol Scand. 2009 Dec;120(6):430-5. doi: 10.1111/j.1600-0404.2009.01187.x. Epub 2009 Jun 10.

PMID:
19519805
25.

Proteomics Discovery of Disease Biomarkers.

Ahram M, Petricoin EF.

Biomark Insights. 2008 Jun 6;3:325-333.

26.

An introduction into proteomics and its clinical applications.

Ahram M.

Saudi Med J. 2007 Apr;28(4):499-507. Review.

PMID:
17457467
27.

Estimation of membrane proteins in the human proteome.

Ahram M, Litou ZI, Fang R, Al-Tawallbeh G.

In Silico Biol. 2006;6(5):379-86.

PMID:
17274767
28.

Characterization of medium conditioned by irradiated cells using proteome-wide, high-throughput mass spectrometry.

Springer DL, Ahram M, Adkins JN, Kathmann LE, Miller JH.

Radiat Res. 2005 Nov;164(5):651-4.

PMID:
16238442
29.

Large-scale proteomic analysis of membrane proteins.

Ahram M, Springer DL.

Expert Rev Proteomics. 2004 Oct;1(3):293-302. Review.

PMID:
15966826
30.

Identification of shed proteins from Chinese hamster ovary cells: application of statistical confidence using human and mouse protein databases.

Ahram M, Strittmatter EF, Monroe ME, Adkins JN, Hunter JC, Miller JH, Springer DL.

Proteomics. 2005 May;5(7):1815-26.

PMID:
15815987
31.

A proteomic approach to characterize protein shedding.

Ahram M, Adkins JN, Auberry DL, Wunschel DS, Springer DL.

Proteomics. 2005 Jan;5(1):123-31.

PMID:
15672459
32.

Expression microdissection: operator-independent retrieval of cells for molecular profiling.

Tangrea MA, Chuaqui RF, Gillespie JW, Ahram M, Gannot G, Wallis BS, Best CJ, Linehan WM, Liotta LA, Pohida TJ, Bonner RF, Emmert-Buck MR.

Diagn Mol Pathol. 2004 Dec;13(4):207-12.

PMID:
15538110
33.

Characterization of plasma membrane proteins from ovarian cancer cells using mass spectrometry.

Springer DL, Auberry DL, Ahram M, Adkins JN, Feldhaus JM, Wahl JH, Wunschel DS, Rodland KD.

Dis Markers. 2003-2004;19(4-5):219-28.

34.

Molecular profiling of cancer.

Gillespie JW, Gannot G, Tangrea MA, Ahram M, Best CJ, Bichsel VE, Petricoin EF, Emmert-Buck MR, Chuaqui RF.

Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:67-71. Review.

PMID:
15209405
35.

Approaches to proteomic analysis of human tumors.

Ahram M, Emmert-Buck MR.

Methods Mol Biol. 2003;222:375-84.

PMID:
12710699
36.

Evaluation of ethanol-fixed, paraffin-embedded tissues for proteomic applications.

Ahram M, Flaig MJ, Gillespie JW, Duray PH, Linehan WM, Ornstein DK, Niu S, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR.

Proteomics. 2003 Apr;3(4):413-21.

PMID:
12687609
37.

Post-analysis follow-up and validation of microarray experiments.

Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V, Emmert-Buck MR.

Nat Genet. 2002 Dec;32 Suppl:509-14. Review.

PMID:
12454646
38.

Evaluation of non-formalin tissue fixation for molecular profiling studies.

Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR.

Am J Pathol. 2002 Feb;160(2):449-57.

39.

Proteomic analysis of human prostate cancer.

Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR.

Mol Carcinog. 2002 Jan;33(1):9-15.

PMID:
11807953
40.

The role of tissue microdissection in cancer research.

Gillespie JW, Ahram M, Best CJ, Swalwell JI, Krizman DB, Petricoin EF, Liotta LA, Emmert-Buck MR.

Cancer J. 2001 Jan-Feb;7(1):32-9. Review.

PMID:
11269646
41.

Rac1-induced endocytosis is associated with intracellular proteolysis during migration through a three-dimensional matrix.

Ahram M, Sameni M, Qiu RG, Linebaugh B, Kirn D, Sloane BF.

Exp Cell Res. 2000 Nov 1;260(2):292-303.

PMID:
11035924
42.

Unraveling the role of proteases in cancer.

Koblinski JE, Ahram M, Sloane BF.

Clin Chim Acta. 2000 Feb 15;291(2):113-35. Review.

PMID:
10675719
43.

Exon 2 of human cathepsin B derives from an Alu element.

Berquin IM, Ahram M, Sloane BF.

FEBS Lett. 1997 Dec 8;419(1):121-3.

44.

Oncogenic c-Ki-ras but not oncogenic c-Ha-ras up-regulates CEA expression and disrupts basolateral polarity in colon epithelial cells.

Yan Z, Deng X, Chen M, Xu Y, Ahram M, Sloane BF, Friedman E.

J Biol Chem. 1997 Oct 31;272(44):27902-7.

45.

Photoproduct formation during irradiation of tissues containing protoporphyrin.

Ahram M, Cheong WF, Ward K, Kessel D.

J Photochem Photobiol B. 1994 Nov;26(2):203-4. No abstract available.

PMID:
7815194

Supplemental Content

Support Center